Skip to main content
Medical information Clinical review pending

Infection Testing

Culture Clostridium Difficile Test

Detects Clostridium Difficile bacteria in stool samples, crucial for diagnosing infections causing severe gastrointestinal issues like diarrhea and abdominal pain. Uses anaerobic culture methods.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
5 g (1 g minimum) fresh stool sample collected in an anaerobic transport medium.
Results
Sample daily by 3:30 PM; report available in 8 days. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test.
Test priceKSh 2,948

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Culture Clostridium Difficile Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Persistent or severe diarrhea
  • ✓Abdominal pain or cramping
  • ✓Fever
  • ✓Recent antibiotic use
  • ✓Recent hospitalization
  • ✓History of gastrointestinal issues
  • ✓Suspected Clostridium Difficile infection
02

In plain language

What this test helps you understand

This test helps identify the presence of Clostridium Difficile bacteria in stool, aiding in the diagnosis of Clostridium Difficile infection (CDI), a common cause of antibiotic-associated diarrhea and colitis.
The Culture Clostridium Difficile Test is a vital diagnostic tool used to detect the presence of Clostridium Difficile, a bacterium responsible for causing severe gastrointestinal infections. This test is particularly important for patients who exhibit symptoms such as persistent diarrhea, abdominal pain, and fever. By identifying the presence of this bacterium, healthcare providers can initiate appropriate treatment, thereby preventing complications associated with the infection.

This test measures the presence of Clostridium Difficile in stool samples. It employs conventional anaerobic culture methods and automated identification techniques to ensure accurate and reliable results. The test does not include antibiotic sensitivity, focusing solely on the detection of the bacterium.

Individuals experiencing symptoms such as frequent diarrhea, abdominal pain or cramping, fever, or recent antibiotic use are encouraged to consider this test. Additionally, those with a history of gastrointestinal issues or recent hospitalizations should also discuss this test with their healthcare provider.

Benefits of taking the test include accurate detection of Clostridium Difficile infections, helping guide appropriate treatment options, preventing complications associated with untreated infections, and convenient testing options with home sample collection available.

Results from the Culture Clostridium Difficile Test will indicate whether the bacterium is present in your stool sample. A positive result suggests an active infection, while a negative result indicates the absence of the bacterium. It is essential to discuss your results with your healthcare provider to determine the next steps in your treatment.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test.
Sample5 g (1 g minimum) fresh stool sample collected in an anaerobic transport medium.
MethodologyConventional anaerobic culture methods and automated identification techniques are used to detect and identify Clostridium Difficile in the stool sample.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence of Clostridium Difficile but does not determine antibiotic susceptibility. A negative result does not completely rule out infection, especially if the sample was collected after antibiotic treatment.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Clostridium Difficile is a type of bacteria that can cause infections in the colon, leading to symptoms like diarrhea, abdominal pain, and fever. It often occurs after antibiotic use.
This test helps diagnose Clostridium Difficile infection, allowing healthcare providers to start the correct treatment promptly and prevent complications.
A fresh stool sample is required, collected in a specific anaerobic transport medium provided by the laboratory.
A positive result indicates that Clostridium Difficile bacteria were found in your stool sample, suggesting an active infection. Discuss this with your doctor.
No special preparation is required for this test.
Results are typically available in 8 days after the sample is received by the laboratory. Confirm with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp